FENOFIBRIC ACID DELAYED-RELEASE

Graviti Pharmaceuticals Private Limited🇺🇸 United States

FDA Page

Effective Date: Dec 5, 2022
Approval ID: 865b1149-4b66-4150-a023-8448b2c05cd7
Products: 2 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use FENOFIBRIC ACID DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for FENOFIBRIC ACID DELAYED-RELEASE CAPSULES. FENOFIBRIC ACID delayed-release capsule for oral use Initial U.S. Approval: 2008

Quick Stats

Total Products2

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.